SMSPHARMA Financial Statements

SMS Pharmaceuticals Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 36.70 (11) 5.60 (27)
Op profit growth 51.50 (14) 24.80 (16)
EBIT growth 62.40 (17) 32.90 (22)
Net profit growth 98 (0.60) 11.50 (30)
Profitability ratios (%)        
OPM 21.50 19.40 20.20 17.10
EBIT margin 18.20 15.30 16.40 13
Net profit margin 11.10 7.66 6.86 6.50
RoCE 15.90 12.20 16.50 11.50
RoNW 4.12 2.50 2.94 2.60
RoA 2.44 1.53 1.72 1.44
Per share ratios ()        
EPS 7.20 3.86 4.78 4.21
Dividend per share 0.30 0.25 0.25 0.20
Cash EPS 4.75 1.12 1.40 1.10
Book value per share 48.50 41.10 33.60 30.10
Valuation ratios        
P/E 17.30 6.90 15.40 20.40
P/CEPS 26.20 23.70 52.60 77.90
P/B 2.57 0.65 2.19 2.85
EV/EBIDTA 10.20 4.39 7.91 11.30
Payout (%)        
Dividend payout -- -- 6.67 5.94
Tax payout (33) (36) (33) (14)
Liquidity ratios        
Debtor days 50.10 32.30 17.90 34.30
Inventory days 86.50 105 78.90 85.50
Creditor days (54) (49) (53) (82)
Leverage ratios        
Interest coverage (9.20) (5.20) (4.90) (3.70)
Net debt / equity 0.52 0.42 0.47 0.54
Net debt / op. profit 1.77 1.84 1.43 1.83
Cost breakup ()        
Material costs (60) (60) (63) (68)
Employee costs (7.30) (9.60) (7.10) (6.10)
Other costs (11) (11) (10) (9.30)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 563 412 463 438
yoy growth (%) 36.70 (11) 5.60 (27)
Raw materials (340) (246) (290) (296)
As % of sales 60.40 59.80 62.70 67.50
Employee costs (41) (39) (33) (27)
As % of sales 7.31 9.55 7.09 6.15
Other costs (61) (46) (47) (41)
As % of sales 10.80 11.20 10.10 9.26
Operating profit 121 79.90 93.30 74.80
OPM 21.50 19.40 20.20 17.10
Depreciation (22) (22) (20) (19)
Interest expense (11) (12) (15) (15)
Other income 3.45 5.11 2.39 1.45
Profit before tax 91.10 50.80 60.30 41.60
Taxes (30) (18) (20) (6)
Tax rate (33) (36) (33) (14)
Minorities and other 1.56 (1.10) (8.70) (7.10)
Adj. profit 62.50 31.60 31.70 28.50
Exceptional items -- -- -- --
Net profit 62.50 31.60 31.70 28.50
yoy growth (%) 98 (0.60) 11.50 (30)
NPM 11.10 7.66 6.86 6.50
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 91.10 50.80 60.30 41.60
Depreciation (22) (22) (20) (19)
Tax paid (30) (18) (20) (6)
Working capital 79.90 72.40 -- (72)
Other operating items -- -- -- --
Operating cashflow 119 83 20.60 (56)
Capital expenditure 58 51.10 -- (51)
Free cash flow 177 134 20.60 (107)
Equity raised 625 554 522 559
Investments 6.79 (3.30) -- 3.29
Debt financing/disposal 59 10.30 2.40 4.02
Dividends paid -- -- 2.12 1.69
Other items -- -- -- --
Net in cash 867 696 547 461
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 8.47 8.47 8.47 8.47
Preference capital -- -- -- --
Reserves 402 340 313 276
Net worth 411 348 322 284
Minority interest
Debt 255 157 144 146
Deferred tax liabilities (net) 59.20 53.50 46.50 44.80
Total liabilities 724 559 512 475
Fixed assets 464 323 300 287
Intangible assets
Investments 27.30 25.80 27 28.40
Deferred tax asset (net) 5.37 13.80 15.90 21.80
Net working capital 187 187 155 125
Inventories 138 129 136 107
Inventory Days 89.30 114 -- 84.80
Sundry debtors 106 48.80 26 24.20
Debtor days 68.50 43.20 -- 19.10
Other current assets 36.80 71.90 55 42.40
Sundry creditors (82) (49) (50) (40)
Creditor days 53.30 43.60 -- 31.80
Other current liabilities (11) (14) (13) (8.60)
Cash 40.50 9.65 14.90 12.70
Total assets 724 559 512 475
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 60.90 121 175 163 171
Excise Duty -- -- -- -- --
Net Sales 60.90 121 175 163 171
Other Operating Income -- -- -- -- --
Other Income 0.43 2.13 1.36 1.29 1.30
Total Income 61.40 123 176 164 173
Total Expenditure ** 65.40 94.20 128 119 130
PBIDT (4) 29.20 48.20 45.70 42.40
Interest 4.34 4.75 4.82 4.96 2.55
PBDT (8.40) 24.40 43.30 40.80 39.90
Depreciation 7.97 8.10 8.09 8 5.54
Minority Interest Before NP -- -- -- -- --
Tax (3.10) 3.50 7.50 7 5.55
Deferred Tax (22) 2.56 2.73 2.57 6.55
Reported Profit After Tax 8.90 10.30 25 23.20 22.20
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 6.17 8.96 23 23.60 23.10
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 6.17 8.96 23 23.60 23.10
EPS (Unit Curr.) 0.73 1.07 2.72 2.78 2.73
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 8.47 8.47 8.47 8.47 8.47
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) (6.60) 24.10 27.60 28.10 24.80
PBDTM(%) (14) 20.10 24.80 25 23.30
PATM(%) 14.60 8.47 14.30 14.20 13
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity